Valuation eFFECTOR Therapeutics, Inc.

Stocks

Market Closed - OTC Markets Other stock markets 11:05:44 2026-06-26 EDT			5-day change	1st Jan Change
0.000600 ^USD	+200.00%		+200.00%	+200.00%

24-09-10	Tyra Biosciences Names Doug Warner Chief Medical Officer	MT
24-07-07	EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	334.3	17.91	30.2
Change	-	-94.64%	68.61%
Enterprise Value (EV) ¹	304.6	11.88	32.38
Change	-	-96.1%	172.45%
P/E	18.8x	-0.78x	-0.71x
PBR	19.3x	4.58x	-6.01x
PEG	0x	0x	-0x
Capitalization / Revenue	233,760,757x	5,041,796x	-
EV / Revenue	-	-	-
EV / EBITDA	-9.56x	-0.37x	-0.96x
EV / EBIT	-9.55x	-0.37x	-0.96x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	11	-13.76	-16.37
Distribution rate	-	-	-
Net sales	1.43	3.553	-
EBITDA ¹	-31.87	-32.35	-33.73
EBIT ¹	-31.9	-32.4	-33.84
Net income ¹	15.8	-22.66	-35.81
Net Debt ¹	-29.67	-6.029	2.175
Reference price ²	207.000000	10.690000	11.685000
Nbr of stocks (in thousands)	1,615	1,676	2,585
Announcement Date	3/16/22	3/8/23	3/26/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EFFECTOR THERAPEUTICS, INC.	-	-	-	-	2.82K
ARGENX SE	34.2x	8.53x	26.72x	0.05%	55.63B
WUXI APPTEC CO., LTD.	19.78x	6x	13.04x	1.52%	52.25B
BIONTECH SE	-18.16x	4.33x	-7.56x	-.--%	23.07B
INSMED INCORPORATED	-39.15x	12.94x	-37.74x	-.--%	22.41B
WUXI BIOLOGICS (CAYMAN) INC.	21.62x	4.23x	10.97x	-.--%	17.32B
GENMAB A/S	22.36x	4.48x	14.84x	-.--%	15.94B
EXELIXIS, INC.	17.25x	5x	11.74x	-.--%	13.77B
PHARMAESSENTIA CORPORATION	44.46x	16.86x	51x	-.--%	13.47B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-436.4x	29.85x	-3327.81x	-.--%	12.43B
Average	-37.12x	10.25x	-360.53x	0.18%	22.63B
Weighted average by Cap.	-9.80x	8.79x	-172.08x	0.36%